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ABSTRACT
To our knowledge, this is the first series of in vitro studies to investigate the effects of
long-term, high-altitude hypoxemia on the contractility of fetal coronary vessels, namely
the left circumflex, left anterior descending, and right coronary arteries. We have found
that in response to chronic hypoxia, isolated fetal ovine coronary arteries exhibit
attenuated contractile responsiveness to potassium and the thromboxane A2 mimetic.
U46619. Furthermore, long-term, high-altitude hypoxia produced no significant
alteration in the maximum relaxation response and sensitivity to adenosine in all vessel
groups examined. We also addressed the possible role of nitric oxide (NO) in the
pharmacological responsiveness of isolated fetal coronary artery rings to potassium.
U46619, and adenosine by conducting paired studies in the absence and presence of the
nitric oxide synthase (NOS) inhibitors, Noo-nitro-L-arginine (L-NNA) and Nco-nitro-L-
arginine ester (L-NAME). Our data suggest that basal nitric oxide production plays
little if any physiological role in the reactivity of isolated fetal coronary arteries to these
agonists under control and chronically hypoxic conditions. Exposure to long-term, high- 
altitude hypoxia resulted in decreased maximum Ca2+-activated force in ft-escin
permeabilized left circumflex and left anterior descending preparations. Furthermore, 
enhancement of Ca +-activated force by U46619 was attenuated in the high-altitude left 
circumflex coronary rings. Ca“+ sensitivity of the contractile proteins; however, was 
unaltered by chronic hypoxia. One possible explanation for the reduction in contractility 
of fetal coronary arteries exposed to long-term, high-altitude hypoxia is an alteration in 
the extracellular matrix proteins present in the tunica medial layer of the vessels.
l
Anecdotal findings from our laboratory show that vascular remodeling occurs in the 
tunica media layer of the coronary arteries isolated from the high-altitude fetuses. The 
observed decrease in contractile capabilities of the fetal coronary arteries as a result of 
exposure chronic hypoxia may be responsible for the maintenance of blood flow
redistribution to the fetal heart. Our data suggest that changes in the structure and 




Significance of Perinatal Hypoxia
Prolonged hypoxia during the course of pregnancy is a form of fetal stress, which is
associated with increased perinatal morbidity and mortality and cognitive impairment
(White and Beischer, 1990; Buka et al., 1993; Slotkin et af, 1997). Conditions such as
high-altitude, chronic smoking, or cocaine abuse in pregnant women expose the
developing fetus to long-term intrauterine hypoxemia (Ballew and Haas, 1986; Sastry,
1991; Arbeille et al., 1997). The fetus; however, is able to compensate for the
hypoxemia by increasing blood flow to the heart and brain at the expense of blood flow
to the periphery (Cohn et al., 1974; Peeters et al., 1979; Sheldon et al., 1979; Kamitomo
et al., 1993; Richardson et al., 1996). It is the primary goal of this dissertation to
examine the role of the fetal coronary arteries in this physiological adaptation to long­
term, high-altitude hypoxemia.
Perinatal Hypoxia and Blood Flow Redistribution: An Overview
Late gestation is a critical period in the development of the mammalian heart and
cardiovascular system. The coronary circulation is the major determinant of myocardial
oxygen balance. The demand for increased circulation to various vital organs during
growth is met by the redistribution of cardiac output (Rudolph and Heymann, 1970).
During the fetal stress of hypoxia, decreased cardiac output with redistribution of blood
flow to the brain, heart, and adrenals at the expense of the peripheral organs occurs.
This protective cardiovascular adaptation of maintenance of blood flow and oxygen
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delivery to these critical fetal organs has been well documented in the ovine model
exposed to acute hypoxia (Cohn et al., 1974; Peeters et al., 1979; Richardson et al..
1996). Previous studies in our laboratory have shown that maintenance of redistribution
of fetal cardiac output to the brain and heart, was maintained during exposure to long­
term intrauterine hypoxemia in fetal sheep at levels found in their low-altitude
(normoxic) counterparts (Kamitomo et al., 1993).
Studies have shown that during chronic hypoxemia in preterm and late gestational
fetal sheep, myocardial flow was enhanced suggesting an important alteration in the
coronary vascular bed (Reller et al, 1992). The fetal heart relies on an adequate
oxygenation through the coronary arteries to function. The primary' factor responsible
for perfusion of the myocardium is aortic pressure (Berne and Levy, 1997).
Interestingly, in fetal sheep exposed to high-altitude hypoxemia (Gilbert, 1998), the
observed 7 % reduction in cardiac output could be explained by an increase in arterial
blood pressure or aortic pressure (afterload). Branches of the ascending aorta, the left
and right coronary arteries supply the fetal heart. The left coronary artery with its main
branches, the left circumflex and left anterior descending, supplies most of the left
ventricle and atrium and interventricular septum. The right coronary artery supplies the
right atrium and ventricle, interventricular septum, and the SA and AV nodes.
Little is known about the regulation or the potential for adaptation of the coronary
circulation during fetal compromise; however, studies conducted on fetal cerebral blood
vessels have been well documented. In response to 15 minutes of moderate hypoxia.
significant relaxation was observed in the basilar, middle cerebral, and posterior
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communicating arteries isolated from fetal lambs (Gilbert et al., 1990). Longo and
Pearce (1991) demonstrated that in response to long-term intrauterine hypoxemia
exposure, isolated fetal cerebral vessels exhibit reduced maximal contractions to 122
mM potassium when compared to normoxic controls. Longo et al. (1993) further
described that chronic hypoxemia depressed both vascular smooth muscle and
endothelial function in fetal cerebral arteries. In response to long-term hypoxemia.
isolated fetal intracranial arteries exhibited values of potassium-induced contractions
which were generally depressed relative to corresponding age-matched normoxic
controls and depressed vasorelaxant responses to the endothelium-dependent vasodilator
A23187. These observations substantiate the significance of cerebral vasculature in the
regulation of blood flow responses during fetal exposure to long-term, high-altitude
intrauterine hypoxemia.
Based on observations in the fetal cerebral vasculature, one might infer that the
coronary arteries play a similar role in the selective redistribution or preferential
streaming of blood flow to the fetal heart during exposure to long-term, high-altitude
hypoxemia. More specifically, chronic hypoxia may cause alterations in the contractile
capabilities of the fetal coronary arteries, which in turn, may be an underlying
mechanism involved in the maintenance of blood flow redistribution to the fetal heart.
Coronary Artery Contractility and Cellular Mechanisms
Alterations in intracellular free Ca2+levels appear to be the common final pathway 
through which all the various physiological control factors and vasoactive agents exert
their effects on vascular smooth muscle (Mohrman and Heller, 1991). Various agonists
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(e.g., thromboxane A2 mimetic, U46619) which bind to their specific receptors located
on the cell membrane are functionally linked via G-protein complexes to second
messenger systems (e.g., phosphoinositide pathway). Most contractile stimuli induce
arterial smooth muscle contraction by increasing intracellular calcium concentration 
[Ca2 ], via release from the sarcoplasmic reticulum (Somlyo, 1985). Four atoms of Ca 
bind with one molecule of calmodulin. This Ca2+-calmodulin complex removes the 
autoinhibition of the enzyme, myosin light chain kinase (MLCK). The activated MLCK
2+
phosphorylates the 20-kd light chain of myosin and causes the activation of the actin-
myosin complex, leading to smooth muscle (coronary artery) contraction (Hathaway et 
al., 1991; Rembold, 1992). The Ca2+ sensitivity of the contractile apparatus is an
important regulator of vascular smooth muscle contractions, which can be modified by
physiological mechanisms (Karaki, 1989; Somlyo and Somlyo, 1994). One of the
primary goals of our study is to examine the effects of long-term, high-altitude hypoxia
t 24"on the Ca" sensitivity of fetal coronary artery myofilaments.
Coronary Artery Morphology and Vascular Remodeling
All major branches of the coronary vascular bed characteristic of the adult heart are
present by the end of the ninth week of gestation. The number of large arteries in man is
more or less fixed at birth (Hudlicka and Brown, 1996). Arteries are thick-walled
vessels that contain, in addition to smooth muscle, a large component of elastic and
collagen fibers. In the immediate perinatal period, rapid elastin and collagen
accumulation correlates with developmental changes in blood flow in the aortas of sheep
(Bendeck and Langille, 1991). The elastin fibers provide vessels with the required
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resilience so they can recoil after stretch while the inelastic component, collagen, is
interwoven between the elastic fibers to limit the extent of stretching and prevent tearing
of the vascular smooth muscle.
Vascular remodeling or vasoconstruction is an active process of structural alteration
(e.g., rearrangement of the cellular and noncellular components of the vessel wall) which
may play a role in the redistribution of cardiac output. Extracellular matrix proteins.
such as elastin, modulate vascular cell function and provide structural support (Cribbons
and Dzau, 1994). Little work has been carried out on the effects of hypoxia on vascular
remodeling in fetal coronary vessels. There are, however, numerous morphological
studies on fetal pulmonary arteries with regards to exposure to hypoxia.
Increased elastin and collagen (extracellular matrix proteins) production (Stenmark et
al., 1987; Durmowicz et al., 1991) is an anatomic change observed within the pulmonary
arteries isolated from neonatal calves exposed to simulated high altitude (Crouch et al..
1989) and chronic hypobaric hypoxia (Badesch et al., 1989). This observed alteration in
the extracellular matrix accumulation may contribute towards the decreased fetal
pulmonary blood flow associated with acute hypoxemia (Faridy et al., 1988; Iwamoto et
al., 1989) and increased contractile efficacy and sensitivity to serotonin in isolated
pulmonary arteries exposed to long-term hypoxia (Umezaki et al., 1999). Based on the
findings in the fetal pulmonary circulation, one might infer that the opposite occurs in
the fetal coronary circulation. Current studies are underway in our laboratory to examine
the effects of chronic hypoxia on the morphology of fetal coronary arteries.
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The primary objective of the studies in this dissertation is to detennine the role of the
coronary arteries in the maintenance of blood flow redistribution to the fetal heart during
exposure to long-term, high-altitude hypoxia. We chose to study sheep because effects
of varying degrees of fetal and neonatal hypoxia on the redistribution of blood flow to
the heart have been well documented in this animal model (Cohn et al., 1974; Peeters et
al, 1979; Sheldon et al., 1979; Richardson et al., 1996).
Specific Goals and Objectives
This project is designed to examine the effects of long-term, high-altitude hypoxia on
the contractility of fetal coronary arteries and its possible contribution to redistribution
of blood flow to the fetal heart. Chapters 2 is a manuscript that has been submitted for
publication while Chapter 3 is a manuscript in the processing phase for publication
submission. Chapter 4 discusses anecdotal findings from a new set of studies being
conducted in our laboratory, and Chapter 5 summarizes the conclusions.
Based on previous findings in our laboratory (Kamitomo et al., 1993; Gilbert, 1998),
we developed the following hypotheses:
1. Long-tenn, high-altitude hypoxia decreases the contractile capabilities of the fetal
coronary arteries.
2. The attenuation of the contractile responsiveness is caused by decreased calcium
sensitivity of the contractile apparatus in the fetal coronary arteries.
3. Chronic hypoxia decreases agonist (U46619) induced calcium sensitization of the
fetal coronary artery myofilaments.
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4. Decreased coronary artery contractility may contribute to the maintenance of blood
flow to the fetal heart during exposure to long-term, high-altitude hypoxemia.
The investigation of our proposed hypotheses was complicated by the paucity of
literature pertaining to the effects of chronic hypoxia on the development, function, and
pharmacological responsiveness of fetal coronary arteries. In this dissertation, the
hypotheses are tested in the studies described in Chapters 2 and 3. Chapter 2: Effects of
Long-Term, High-Altitude Hypoxemia on Isolated Fetal Ovine Coronary Arteries. This
study determined that exposure to chronic hypoxia decreased coronary artery
contractility to potassium and the thromboxane A2 mimetic, U46619. However, the
vasorelaxant response to adenosine was unaltered by long-term hypoxia. Chapter 3: 
Cax Sensitivity of Fetal Coronary Arteries Exposed to Long-Term, High-Altitude 
Hypoxemia. Contrary to our hypothesis, Ca“+ sensitivity of the contractile apparatus in 
fetal coronary arteries is unaltered by chronic hypoxia; however, maximum Ca 
activated force was attenuated in high-altitude left circumflex and left anterior
2+
descending (3-escin permeabilized preparations. In support of our third hypothesis, we 
were able to demonstrate that U46619-enhanced Ca2+ sensitization of myofilaments was
attenuated by chronic hypoxia. Chapter 4 is a brief discussion of anecdotal findings of
experiments currently underway in the laboratory. Our preliminary studies indicate that
coronary arteries isolated from fetal sheep exposed to chronic hypoxia exhibit an
alteration in the elastin deposition of the tunica medial layer. Finally, Chapter 5 is the
conclusion of this dissertation which encompasses the significance of changes in the
10
structure and function of coronary arteries to the maintenance of blood flow
redistribution to the fetal heart during exposure to long-term, high-altitude hypoxia.
11
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CHAPTER2
EFFECTS OF LONG-TERM, HIGH-ALTITUDE HYPOXIA ON ISOLATED
FETAL OVINE CORONARY ARTERIES
Felizabel C. Garcia1, Virginia M. Stiffel2, and Raymond D. Gilbert3
Student who conducted all the experiments, collected the data, and prepared the
manuscript
2Research technician who helped conduct some experiments 





We studied the contractile properties of isolated coronary arteries in near-term fetal
lambs exposed to long-term, high-altitude hypoxia. Maximum contractile responses
(Tmax) to 90 mM KC1 and the thromboxane A2 mimetic, U46619, were measured in
proximal (PLCx) and distal left circumflex (DLCx), left anterior descending (LAD), and
right coronary artery (RCA) rings from high altitude (HA) and control (CON) fetuses
(n=9-18 for each group). Paired studies were conducted with and without nitric oxide
synthase (NOS) inhibitors Nco-nitro-L-arginine (l-NNA) and Nco-nitro-L-arginine ester
(L-NAME). In HA fetuses, 90 mM KC1 Tmax responses, in both intact and NOS blocked
rings decreased by: ~ 62% in PLCx, ~ 59% in DLCx, ~ 57% in LAD, and ~ 47% in
RCA. HA vessels also exhibited decreased sensitivity to U46619. NOS blockade
potentiated Tmax to U46619 in HA RCA and augmented Tmax to U46619 in HA RCA
when compared to its treated CON counterpart. These results suggest that nitric oxide 
influences the pharmacological responsiveness of HA RCA to U46619. Furthermore,
chronic hypoxemia significantly alters the contractile capabilities of fetal coronary
arteries. These observations may partially explain the maintained redistribution of
cardiac output to the fetal heart during exposure to long-term, high-altitude hypoxemia.
Index terms: coronary artery, thromboxane A2, nitric oxide synthase
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Introduction
There are numerous conditions in which the developing fetus is exposed to long-term.
intrauterine hypoxemia. Some factors include: 1) where the mother resides e.g., high
altitude (Ballew and Haas, 1986), 2) health status of the mother e.g., anemia (Mostello
et al., 1991), 3) activities of the mother e.g., smoking or cocaine abuse (Sastry, 1991;
Arbeille et al., 1997), and 4) pathological problems which affect oxygen transfer e.g.,
placental insufficiency (Kingdom and Kauffnann, 1997).
Studies have shown that in response to acute hypoxia, the fetus develops
cardiovascular adaptations to protect vital organs which includes redistribution of
arterial blood flow to the brain, heart, and adrenals at the expense of the peripheral
organs (Peeters et al., 1979; Richardson et al., 1996). Studies conducted in our
laboratory demonstrated that exposure to long-term (100-110 days) hypoxemia in fetal
sheep resulted in a reduction in cardiac output and a maintenance of blood flow to the
brain and heart (Kamitomo et al., 1993). Other studies have shown that during chronic
hypoxemia in preterm and late gestation fetal sheep, myocardial flow was enhanced
suggesting an important alteration in the coronary vascular bed (Reller et al, 1992).
The fetal heart relies on an adequate oxygen supply through the coronary arteries to
function. Little work has been carried out on fetal coronary vasculature; however,
studies on fetal cerebral blood vessels have been well documented. Chronic hypoxemia
depresses both vascular smooth muscle and endothelial function in the fetal cerebral
vessels. Longo and Pearce (1991) demonstrated that in response to long-term
intrauterine hypoxemia exposure, isolated fetal cerebral vessels exhibit reduced maximal
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contractions to potassium. Longo et al. (1993) described that chronic hypoxemia 
depressed endothelium-dependent vasodilator responses in fetal cerebral arteries. These 
observations substantiate the significance of the cerebral vasculature in the regulation of 
blood flow responses during fetal exposure to long-term intrauterine hypoxemia. Based 
on these observations in the cerebral vasculature, we hypothesized that a similar 
reduction in the contractile response occurs in the fetal coronary vasculature. K+ and
U46619 (thromboxane A2 mimetic) were selected as contractile agents and adenosine as
the relaxant agent because these substances are chemical mediators that modify coronary
arterial tone in intact hearts. In addition, the concentration of thromboxane (Coker et al..
1981) and adenosine (Minamino et al., 1995) have been reported to increase during
periods of acute hypoxia and ischemia. Studies by Reller et al. (1995) suggest that nitric
oxide plays a significant role in the regulation of fetal myocardial flow during
hypoxemic stress. To address the possible role of nitric oxide (NO) in the fetal coronary
circulation under chronic hypoxic conditions, we conducted paired studies in the absence
and presence of nitric oxide synthase (NOS) inhibitors, Nco-nitro-L-arginine (L-NNA)
and Nco-nitro-L-argmine ester (L-NAME).
The results described in our study represent the first demonstration of the effects of
long-term, high-altitude hypoxia in isolated fetal coronary arteries. Our results suggest
that in response to chronic hypoxia, fetal coronary arteries exhibit decreased contractile
responses to potassium and U46619. This in turn, may be an underlying mechanism




Isolated smooth muscle preparations
Fetal sheep were obtained from pregnant ewes that had been maintained near sea
level (~ 300 m, arterial P02 = 102 + 2 mmHg) or at high altitude (Barcroft Laboratory,
White Mountain Research Station, Bishop, CA, altitude 3,820 m, arterial PO2 = 64 + 2
mmHg) for 100-110 days beginning on day 30 gestation (term =146 days). The latter
group of animals was transported (~ 7-h trip) to our laboratory at Loma Linda University
Medical Center (elevation 346 m). Immediately upon arrival a nonocclusive maternal
tracheal catheter was surgically placed to reestablish chronic hypoxia by administration
of nitrogen gas.
On the experimental day, the ewes were sedated intravenously with pentobarbital.
intubated, and maintained under general anesthesia with 1.5-2% halothane in oxygen
while we delivered the fetuses through a midline laparotomy. Fetuses ranged in age
from 139 to 141 days gestation (control 140 + 0.3 and hypoxic 139 + 0.2). We
immediately removed the fetal hearts via midline thoracotomy and placed them in
chilled Tyrode's solution. Proximal segments (> 1.6 mm od) of the right coronary artery
(RCA), left anterior descending (LAD), and left circumflex (PLCx) coronary arteries
were dissected free from the hearts and cleared of connective tissue and fat. Distal
segments of the LCx (DLCx) (1.4 mm od) were also collected. All side branches were
excised. The coronary arterial segments were then cut into rings measuring 3-4 mm in
length with special care taken to avoid stretching and damage to the luminal surface.
The coronary artery ring segments were mounted horizontally between two tungsten
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wire triangles, one attached to a fixed post and the other to an isometric force transducer 
(Radnoti Glass, model 159901 & 159902, Monrovia, CA). The artery rings were placed 
in a water-jacketed (20 ml) organ chamber (Radnoti Glass, Monrovia, CA) filled with
Krebs solution (pH 7.3; 37°C) containing (in mM): NaCl 122, NaHCCb 25.6, glucose
5.56, KC1 5.17, MgS04 2.49, CaCl2 1.6, and disodium EDTA 0.027 along with 10
indomethacin to inhibit prostanoids. Vessel segments from both the control (CON) and
high altitude (HA) groups were studied with the bath solution aerated with 95% O2: 5%
C02.
Paired coronary artery studies had baths designated as +/- Nco-nitro-L-arginine (L- 
NNA, 10'4 M) and Nco-nitro-L-arginine methyl ester (l-NAME, 10‘4 M) indicating the
presence or absence of the L-arginine analogues which served as inhibitors of nitric
oxide synthase (NOS). The functional integrity of the endothelium was assessed with
the endothelium-dependent vasodilator, substance P (Kuroiwa et al., 1995; Dulas et al..
1996). Endothelium intact coronary rings precontracted with 60 mM KC1 demonstrated 
relaxation to substance P (10'9 to 10° M), whereas no relaxation was shown in response
to this agent in NOS blocked rings.
Experimental protocol
Arterial rings were equilibrated for 1 hour at their optimal resting tension of 0.7 g
(control group) and 0.3 g (high altitude group). In preliminary experiments, these
resting tensions were found to result in the greatest tension development to 90 mM KC1.
After equilibration, rings were challenged with KC1 (90 mM) until constant and
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reproducible contractions were achieved (usually twice). After the K+ response, the 
baths were refilled with Krebs solution and vessel rings were allowed to reequilibrate for
30 minutes. After equilibration, a half-log increment cumulative concentration-response 
curve for the thromboxane A2 mimetic, U46619 (10'10 to 10'5 M) was generated. Next,
to test relaxation responses, the rings were precontracted with the EC50 dose of U46619
calculated for each individual vessel segment and a cumulative concentration-response 
curve for adenosine (10'9 to 10'4 M) was obtained. Contractile and relaxant responses
were measured and analyzed by on-line data acquisition software (Labview 2.2.1,
National Instruments, Austin, TX) and data were normalized to vessel cross-sectional 
area (gm/cm2). Cross-sectional area was calculated by the following formula:
weight/(density (length), with a value of 1.06 used for the density of wet tissue
(McMahon and Paul, 1986).
Chemicals
U46619 (9,11-dideoxy-l la,9a-epoxymethanoprostaglandin p2a dissolved in methyl
acetate solution), adenosine, Neo-nitro-L-arginine (L-NNA) and Nco-nitro-L-arginine
methyl ester (l-NAME) were purchased from Sigma Chemical (St. Louis, MO). All
other chemicals were of the highest grade available and purchased from Sigma or Fisher.
Statistical analysis
For each vessel ring, maximum tension, excitatory pD2, and inhibitory pD2 values
were determined from the concentration-response curves and averaged for each
24
experimental group. All values were expressed as means + SE, with n representing the 
number of animals examined. Statistical significance (p< 0.05) was assessed using a




As shown in Figure 1, chronic hypoxemia caused a significantly depressed maximum
contractile response (Tmax) to 90 mM KC1 in all the coronary artery segments studied. In
intact preparations, Tmax values decreased by: ~ 62% in the PLCx (HA 0.077 + 0.014
vs CON 0.251 ± 0.023 gm/cm2, ^ < 0.05), ~ 59% in the DLCx (HA 0.150 + 0.020 vs
CON 0.399 ± 0.036 gm/cm2,/? < 0.05), ~ 57% in the LAD (HA 0.116 ± 0.022 vs CON
0.324 ± 0.026 gm/cm2, p < 0.05), and ~ 47% in the RCA (HA 0.111 ± 0.014 vs CON
0.230 + 0.020 gm/cm2,p < 0.05). The response to 90 mM KC1 was not altered by
blockade of NOS with L-NNA and L-NAME (Figure 1).
Contractile responses: U46619
The thromboxane A2 stable analogue, U46619, caused concentration-dependent
contractions of all the coronary artery ring segments studied. As shown in Table 1,
chronic hypoxemia produced no significant alteration in the maximum U46619 response
(Tmax) in either intact or NOS blocked PLCx, DLCx, or LAD. In the RCA the Tmax
response to U46619 was unchanged by L-NNA/L-NAME in the control group.
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However, in the high altitude group, NOS blockade resulted in a ~ 77% increase in
Tmax (Table 1). This resulted in the Tmax response to U46619 in the high altitude, L-
NNA/L-NAME treated RCA to also be significantly higher (~ 158%) than in the control,
NOS blocked RCA (Table 1, Figure 2).
Chronic hypoxemia produced a significant decrease in sensitivity to U46619, as
measured by the excitatory pDi, in the PLCx (Figure 3), as well as in all coronary artery
groups studied (Table 2). This response was unaltered by l-NNA/l-NAME treatment in
all of the vessels studied (Table 2).
Relaxant responses: adenosine
As shown in Figure 4, adenosine caused a concentration-dependent relaxation in the
PLCx, as well as in all coronary artery segments studied (rings were precontracted with
the EC50 dose of U46619 calculated for each individual vessel segment). Chronic
hypoxemia produced no significant alteration in the maximum ADO relaxation response
in the vessels studied (Table 3). In addition, in both the control and high altitude groups.
NOS blockade with L-NNA and L-NAME produced no significant alteration in the
adenosine relaxation responses (Table 3). Furthennore, sensitivity to adenosine, as
measured by the inhibitory pD2, was not altered by chronic hypoxemia or by
pharmacological blockade of NOS in all of the coronary artery groups studied (Table 4).
Discussion
To our knowledge these are the first in vitro studies demonstrating the effects of
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chronic hypoxia (-110 days) on the contractility and relaxation of fetal ovine coronary 
arteries. K+ and U46619 (thromboxane A2 mimetic) were chosen as the contractile
agents and adenosine as the relaxant agent because these substances are chemical
mediators that modify coronary arterial tone in intact hearts. In addition, the
concentration of thromboxane (Coker et al., 1981) and adenosine (Minamino et al..
1995) have been reported to increase during periods of ischemia and acute hypoxia.
Thromboxane A2 (TXA2) is a prostaglandin endoperoxide and potent vasoconstrictor
released from aggregating platelets (Ogletree, 1987). U46619 is a selective TXA2
mimetic (Coleman et al., 1981) and widely used as a contractile agent in isolated
coronary artery preparations from the sheep, pig, dog, and human (Ohlstein et al, 1988;
Dalen et al., 1994; Yamagishi et al., 1994). Adenosine is a potent dilator of coronary
vessels (Berne, 1980) and one of the primary physiological transmitters that couples
coronary blood flow to myocardial metabolism.
Effects of chronic hypoxemia'.
The present experiments demonstrate that in isolated coronary artery rings from fetal
sheep, chronic hypoxemia decreased the maximum developed tension (Tmax) to 90 mM
KC1 in all coronary artery segments studied. In coronary artery rings isolated from adult
sheep, exposure to acute hypoxic conditions also resulted in a decrease in the contractile
effects of potassium (Kwan et al., 1989a). Contraction induced by KC1 results from the 
influx of Ca2+ from the extracellular space (EC) and is independent of membrane
receptors and second messenger systems. Possible mechanisms for the reduction in the
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contractile responses to KC1 (Fig. 1) might include a decrease in Ca"+influx across the 
smooth muscle cell membrane or altered the Ca2+ sensitivity of the contractile elements
in fetal coronary arteries exposed to chronic hypoxemia.
Exposure to long-term, high altitude hypoxemia produced a significant decrease in
sensitivity to U46619 in all of the fetal ovine coronary artery groups (Table 2).
However, there was no significant influence of chronic hypoxemia on the maximum
contractile response to U46619 in the PLCx, DLCx, and LAD (Table 1). Only the high 
altitude L-NNA/L-NAME treated RCA demonstrated an enhanced response to U46619 
(Figure 2). U46619 mediates vascular smooth muscle contraction by release of Ca2+from 
intracellular stores (Dorn and Becker, 1993), by increasing Ca2+sensitivity of the
2+contractile apparatus (Jiang et al., 1994), and by increased influx of extracellular Ca
which may play a dominant role in sustaining U46619-induced contractions (Jiang et al..
1994). Which one or more of these factors that has changed in response to long-tenn
hypoxemia in these fetal coronary arteries is not known.
Our U46619 results differ from those observed in adult sheep. Kwan et al. (1989a)
demonstrated in endothelium-intact adult LCx rings that exposure to acute hypoxia
resulted in potentiation of the maximum active tension and sensitivity to U46619.
However, studies by Dalen et al. (1994) have shown an attenuation of the
vasoconstrictor effect of U46619 in intact LCx preparations when exposed to acute
hypoxia. The differential effect of hypoxia on the pharmacological responsiveness to
U46619 between isolated fetal and adult coronary arteries may be partially explained by
the differences in the degree and mechanism of production of hypoxemia. In the adult
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studies, acute hypoxia was accomplished by lowering the PO2 of the bathing solution for
a matter of minutes. In our studies, the coronary arteries were isolated from fetuses
exposed to long-term (approx. 100-110 days) maternal hypoxemia. In addition.
structural and functional changes in the coronary arteries associated with growth and
development cannot be ruled out.
It has been well documented that adenosine and its analogues cause vasorelaxation of
isolated coronary artery preparations in various species including canine (White and
Angus, 1987), porcine (Abebe et al., 1995), and human (Sabouni et al., 1991).
Adenosine also caused relaxation in isolated fetal ovine coronary artery rings (Table 3),
however, chronic hypoxemia produced no significant alterations in the maximum
relaxation response and sensitivity to adenosine in all vessel groups examined (Tables
3,4). It has been shown in canine perfusion studies by Stepp et al. (1997) that adenosine
is not necessary for coronary autoregulation. Furthermore, the intrinsic ability of the
coronary arteries to maintain blood flow to the heart may involve substances other than
adenosine (Feigl, 1989). Our data suggests that adenosine plays little if any
physiological role in the response of fetal ovine coronary arteries exposed to chronic
hypoxia.
Effects of NOS blockade:
Based on our experiments, basal NO production plays little, if any role in the K
mediated contraction of all coronary artery segments and in U46619 mediated
contractions in the PLCx, DLCx, and LAD. In addition, NO was not involved in the
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response to chronic hypoxia in these vessel segments.
In RCA isolated from high altitude ovine fetuses, however, pharmacological blockade
of NOS augmented the maximum contractile effect of U46619 (Table 1). When
compared to its control counterpart, NOS blockade enhanced the U46619 response in the
high altitude RCA (Table 1, Figure 2). It has been reported that the right coronary artery
is more responsive to U46619, as compared to the left circumflex and left anterior
descending coronary arteries (Kanmura et al., 1986). In our experiments, inhibition of
nitric oxide via the pharmacological blockade of NOS with l-NNA/l-NAME appeared
to play a more important role in the high-altitude RCA (Table 1, Figure 2). In RCA
rings isolated from fetal sheep exposed to chronic hypoxemia, pharmacological blockade
of NOS resulted in increased maximum response to U46619. Furthermore, when
compared to their control counterparts, L-NNA/L-NAME treated HA RCA rings
exhibited increased maximal response to U46619 (pD2 values were also increased).
Based on our in vitro studies, these observations suggest that basal NO production plays
an important role in the pharmacological responsiveness to U46619 in HA RCA of fetal
sheep. Several questions still remain concerning the participation of the endothelium in
the responses we observed. We did not examine chemically or flow induced changes in
NO production and release and their effect on those responses. Also, because we only
eliminated the effects of NO with l-NNA/l-NAME and prostanoids with indomethacin.
we cannot rule out the participation of other endothelial derived factors such as
endothelial-derived hyperpolarizing factor (EDHF) and its possible contribution to the
control of coronary blood flow (Eckman et al., 1998; Popp et al., 1998).
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Conclusion
In conclusion, exposure to long-term, high-altitude hypoxemia significantly alters the
contractile capabilities of isolated fetal coronary arteries. Chronic hypoxia significantly
decreased the maximum contractile response to 90 mM KC1 and sensitivity to U46619 in
all coronary artery groups studied. Maximum relaxation response to adenosine;
however, was unaltered by chronic hypoxia. Nitric oxide did not play a significant role
in the pharmacological responses of CON and HA PLCx, DLCx, and LAD to these
agonists. Basal nitric oxide production appeared to only influence the pharmacological
responsiveness to the thromboxane A2 mimetic U46619 in the RCA. These observations
may contribute towards the general understanding of the adaptive mechanisms in the
coronary arteries involved in the maintenance of blood flow redistribution to the fetal
heart during exposure to long-term intrauterine hypoxemia. Current studies are
underway to examine the role of calcium in the altered contractile capabilities of fetal
coronary arteries due to long-term, high altitude hypoxemia.
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Table 1. Maximum contraction (Tmax) to U46619 in fetal ovine coronary arteries 
exposed to long-term, high-altitude hypoxia.
+ LNNA/LNAMEIntact
Proximal LCx
0.309 + 0.042(18) 
0.207 + 0.043 (10)





0.509 + 0.081 (17) 
0.424 + 0.066 (9)





0.270 + 0.046(15) 
0.285 + 0.020 (9)
0.290 + 0.065 (15) 




0.183 ±0.042 (13) 
0.473 ± 0.107 (10)*§




Results are expressed as means ± SE for number of observations in parentheses. Values 
expressed as gm/cm2 for U46619 (10‘5 M). * Indicates a significant difference (p < 0.05) from 
the intact counterpart. § Indicates a significant difference (p < 0.05) from control counterpart.
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Table 2. Excitatory pD2 (- log M) values for contraction to U46619 in fetal ovine 






6.519 + 0.078(18) 
6.730 + 0.087(16)
6.005 + 0.131 (10)* 





6.618 + 0.066(17) 
6.730 + 0.087(16)







6.627 + 0.071 (15) 
6.578 + 0.077(15)
6.204 + 0.065 (9)* 





6.506 + 0.076(13) 
6.581 + 0.065(10)
6.244 + 0.088 (9)* 
6.226 + 0.102(10)*
Results are expressed as means + SE for number of observations in parentheses. All experiments 
done in the absence (intact) and presence of the NOS inhibitors, L-NNA and L-NAME.
* Indicates a significant difference (p < 0.05) from the value obtained under control conditions.
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Table 3. Effect of long-term, high-altitude hypoxia on % maximum relaxation 





70.17 + 9.517(11) 
63.70 + 7.748 (8)





77.04 + 9.047 (9) 
69.86 + 6.635 (10)





83.87 + 4.109(10) 
69.94 + 8.564(10)





62.99 + 10.08 (9) 
71.15 + 6.538(10)
78.06 + 8.428 (9) 
74.26 + 7.305 (10)
Results are expressed as means + SE for number of observations in parentheses. Values 
expressed as % relaxation for adenosine at 10'4 M. * Indicates a significant difference {p < 0.05) 
from the intact counterpart.
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Table 4. Inhibitory pD2 (- log M) values for relaxation to adenosine in fetal ovine 






4.865 + 0.151 (10) 
4.853 + 0.151 (10)






5.363 ±0.207 (8) 
5.330 ±0.174 (8)
5.318 ± 0.131 (9) 





5.153 ±0.113 (12) 
5.145 ±0.099 (12)






4.950 ±0.159 (10) 
5.253 ±0.124 (9)
5.097 ± 0.142 (10) 
4.902 ± 0.344 (7)
Results are expressed as means ± SE for number of observations in parentheses. All experiments 
done in the absence (intact) and presence of the NOS inhibitors, L-NNA and L-NAME.
* Indicates a significant difference (p < 0.05) from the value obtained under control conditions.
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In this study, we tested whether decreased calcium responsiveness of fetal coronary 
arteries may contribute to previously reported decreased contractile responses to K+ and 
the thromboxane A2 mimetic, U46619, during chronic hypoxemia. Concentration- 
response curves to Ca2+ in b-escin permeabilized left circumflex (LCx), left anterior
descending (LAD), and right coronary artery (RCA) rings from high altitude (HA) and
i
control (CON) fetuses were measured. Maximum Ca" activated force (Tmax) was
decreased in HA LCx (CON 0.091 + 0.010 vs HA 0.057 + 0.006 gm/cm2,/? < 0.05) and 
HA LAD (CON 0.065 + 0.012 vs HA 0.031 + 0.007 gm/cm2,p < 0.05). No significant
difference was observed in the RCA. There was no change in the pD2 (-log EC50) values 
between CON and HA coronary rings. The Ca2+ sensitizing effect of U46619 on 
submaximal Ca activated force was lower only in the HA LCx (CON 0.044 + 0.010 vs 
HA 0.023 + 0.006 gm/cm2 at 10~5 M,p < 0.05). These results indicate that maximum 
tension development in response to Ca2+ was decreased in the HA LCx and LAD but not 
the RCA; however, Ca2+ sensitivity of the contractile apparatus was unaltered in all of 
them. This may partially explain the decreased contractile capability of fetal LCx and 
LAD during long-term, high-altitude intrauterine hypoxemia.
Index terms: intrauterine hypoxemia, Ca2+ sensitivity, thromboxane A2, b-escin
52
Introduction
Previously we have shown that exposure to long-term, high-altitude hypoxemia
resulted in decreased contractile responses of isolated fetal ovine coronary arteries to
potassium and the thromboxane A2 mimetic, U46619 (Garcia et al., submitted). The
purpose of this current study was to test two hypotheses, which may possibly explain the 
observed decrease in contractile capabilities of fetal coronary vessels. Our two 
hypotheses were that in response to long-term, high-altitude hypoxemia, a decrease 
occurs in the: 1) responsiveness of the contractile apparatus to Ca“ in fetal coronary 
arteries and 2) U46619-induced Ca sensitization of the myofilaments. Modulation of 
the Ca" sensitivity of the contractile elements is a key mechanism governing the 
reactivity of vascular smooth muscle (Rembold, 1992; Somlyo and Somlyo, 1994). To
test our first hypothesis, we used p-escin permeabilized preparations in which 
intracellular calcium [Ca ], was held constant by use of calcium chelators and depletion 
of intracellular Ca2+ stores with the calcium ionophore, A23187 (Akopov et al., 1997). In
smooth muscle preparations permeabilized with P-escin, second messenger systems that
9-Tregulate myofilament Ca" sensitivity remain intact (Kobayashi et al., 1989).
In vascular smooth muscle, several studies using P-escin permeabilized preparations
have demonstrated that various vasoactive agents (e.g., serotonin, diosmin) can
2+markedly increase the contractile response to a given submaximal level of Ca
(Savineau and Marthan, 1994; Satoh et al., 1994). To address our second hypothesis, we 
chose to examine the effects of long-term hypoxia on agonist-induced Ca2+ sensitization
utilizing the thromboxane A2 (TXA2) mimetic, U46619. U46619 is widely used as a
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contractile agent in isolated coronary artery preparations from sheep, pig, dog, and
human (Ohlstein et al., 1988; Dalen et al., 1994; Yamagishi et al., 1994).
The results described in our study represent the first demonstration of the effect of 
long-term, high-altitude hypoxia on the Ca2+ sensitivity of fetal coronary arteries. Our
results suggest that the previously reported attenuation in contractile responsiveness to
potassium and U46619 in response to chronic hypoxia may be partially explained 
decreased Ca~ responsiveness in the fetal coronary arteries.
Methods and Materials
Isolated smooth muscle preparations
Fetal sheep were obtained from pregnant ewes that had been maintained near sea
level (~ 300 m, arterial PO2 = 102 + 2 mmHg) or at high altitude (Barcroft Laboratory,
White Mountain Research Station, Bishop, CA, altitude 3,820 m, arterial PO2 = 64 + 2
mmHg) for ~ 110 days beginning on day 30 gestation (term = 146 days). The latter
group of animals was transported (~ 7-h trip) to our laboratory at Loma Linda University
Medical Center (elevation 346 m). Immediately upon arrival a nonocclusive maternal
tracheal catheter was surgically placed to reestablish chronic hypoxia by administration
of nitrogen gas.
On the experimental day, the ewes were sedated intravenously with pentobarbital.
intubated, and maintained under general anesthesia with 1.5-2% halothane in oxygen
while we delivered the fetuses through a midline laparotomy. Fetuses ranged in age
from 138 to 141 days gestation (control 140.7 + 0.4 and high altitude 138.9 + 0.3). We
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immediately removed the fetal hearts via midline thoracotomy and placed them in
chilled Tyrode’s solution. Segments (> 1.6 mm od) of the right coronary artery (RCA),
left anterior descending (LAD), and left circumflex (LCx) coronary arteries were
dissected free from the hearts of control (CON) and high altitude (HA) fetuses and
cleared of connective tissue and fat. All side branches were excised. The coronary
arterial segments were then cut into rings measuring 3-4 mm in length with special care
taken to avoid stretching. Experiments were conducted on endothelium denuded vessels.
Mechanical removal of the endothelium was achieved by rotation of silk suture material
through the lumen of the arterial segments several times. The loss of endothelium
produced by this method was verified by: 1) absence of relaxation to the endothelium-
dependent vasodilator, substance P and 2) histological examination of the tissue samples.
The coronary artery ring segments were mounted horizontally between two tungsten
wire triangles, one attached to a fixed post and the other to an isometric force transducer
(Radnoti Glass, model 159901 & 159902, Monrovia, CA). The artery rings were placed
in a water-jacketed (20 ml) organ chamber (Radnoti Glass, Monrovia, CA) filled with
Krebs solution (pH 7.0; 25°C) containing (in mM): NaCl 122, NaHCCL 25.6, glucose
5.56, KC1 5.17, MgSCL 2.49, CaCf 1.6, and disodium EDTA 0.027. Vessel segments
from both the control (CON) and high altitude (HA) groups were studied with the bath
solution aerated with 100% 02.
After equilibration at optimal baseline stretch (CON = 0.7 g, HA = 0.3 g) for 30 
minutes, contractions induced by 90 mM KC1 (high K+ solution) were measured (usually 
twice) and recorded by on-line computer.
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Solution composition
Two main buffer solutions were prepared, one with zero free calcium (relaxing
solution) which contained (in mM): potassium acetate 65, magnesium acetate 6,
disodium ATP 5, EGTA 10, HEPES 25, and dithiothreitol 1.0 with the pH of the
solution adjusted to pH 7.0 with KOH at 25°C. A second buffer solution contained 100
2-|-
mM Ca^ in addition to the same components in the zero free calcium buffer. The
different free calcium concentrations were prepared by mixing appropriate amounts of 
relaxing solution and Ca2+ standard solution (100 mM) and titrated to pH 7.0 at 25°C 
with 1 M KOH. Ca concentrations ranging from pCa 8.0 to 3.5 were calculated using a 
computer program that was modified to take into account the influence of temperature
on binding constants (Harrison and Bers, 1990). Using a Jasco CAF-110 flurometer, free
24-
Ca" concentrations were measured directly in solution using dual wavelength
measurements of bound to unbound fura-2 ratios at 25°C (Grynkiewicz et al., 1985). All
solutions contained disodium ATP (5 mM) and creatine phosphate (10 mM) to support
contraction of the vessel rings. The protease inhibitor, leupeptin (1.0 jiM) was also
added to all solutions.
Penneabilization procedure
After recording the contractile response to 90 mM KC1, the coronary artery rings
were placed into the zero free calcium relaxing solution. Chemical permeabilization was
achieved by adding 50 ^M to the relaxing solution and allowing the vessel rings to
incubate for 15 minutes at 25°C. The bath solution was aerated with 100% O2 to ensure
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proper mixing of relaxing solution with 50 pM (3-escin. After this period, (3-escin was
removed by rinsing the muscle chamber baths several times with relaxing solution.
To deplete the sarcoplasmic reticulum (SR) of calcium and maintain cytoplasmic 
Ca^ constant, all baths were treated with 1.0 uM calcium ionophore A23187 for 15 
minutes. Depletion was verified by complete absence of contractile responses to caffeine
(25 mM). Following this step, coronary artery rings were equilibrated for 15 minutes in
relaxing solution.
Experimental protocol
Protocol A: pCa-force relationship. Concentration-response curves to Ca2+ (p[Ca2+]
-8.5 to -3.0) were constructed in a cumulative manner in {3-escin permeabilized control
and high altitude coronary artery rings (n=7, for each group). Tension measurements
were recorded by on-line computer.
2-j-Protocol B: Effect of U46619 on Ca activated force. In a second set of (3-escin
permeabilized coronary artery rings, the effect of the thromboxane A2 mimetic, U46619,
2-f
on Ca sensitivity was tested. After incubation in relaxing solution for 15 minutes.
CON and HA LCx and RCA rings (n=9, for each group) were precontracted with a 
submaximal concentration (EC30 = 3 nM) of calcium (previously determined in Protocol 
A). Once a plateau was reached, U46619 was added in a cumulative manner (1010 to 
1 O'3 M) and tension measured by on-line computer.
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Chemicals and drugs
p-escin, creatine phosphate, disodium ATP, leupeptin, calcium ionophore A23187,
dithiothreitol, and U46619 were purchased from Sigma Chemical (St. Louis, MO). All
other reagents were of the highest grade commercially available.
Statistical Analysis
All data are presented as means + SEM. In all cases, n refers to the number of
animals studied. Statistical analysis was carried out using Student’s unpaired t test. P <
0.05 was considered statistically significant.
Results
Contractile responses: potassium
Prior to permeabilization with p-escin, maximum tension (Tmax) induced by 90 mM
KC1 was measured in denuded coronary artery rings (Figure 1). Chronic hypoxemia
caused a significant depression of Tmax to 90 mM KC1 in LCx (CON 0.277 + 0.024 vs 
HA 0.160 ± 0.018 gm/cm2, p < 0.05) and LAD (CON 0.251 ± 0.060 vs HA 0.104 ± 
0.019 gm/cnr, p < 0.05). There was no difference in response of the high altitude RCA 
(0.094 ± 0.014) compared to CON RCA (0.134 ± 0.040 gm/cm2).
pCa-force relationship in permeabilizedfetal coronary arteries
Figure 2 summarizes the concentration-dependent contractions to calcium in
permeabilized vessel segments from both control and high altitude groups. Maximum
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Ca2+ activated force was attenuated in the high altitude LCx (CON 0.091 + 0.010 vs HA 
0.057 + 0.006 gm/cm2, p < 0.05) and high altitude LAD (CON 0.065 + 0.012 vs HA 
0.031 + 0.007 gm/cm",/? < 0.05). No significant difference was observed in the RCA 
(CON 0.033 + 0.009 vs HA 0.028 + 0.006 gm/cm2). As shown in Table 1, there were no
changes in the pD2 (-log EC50) and Hill coefficient values between the control and high
altitude fetal coronary arteries.
Effect of U46619 on Ca 1 activated force
U46619 (1010 to 10° M) was used to investigate agonist-induced Ca2+ sensitization 
of fetal LCx and RCA. In the presence of a constant [Ca2+] of 3 jliM (EC30), increasing 
concentrations of U46619 potentiated the existing Ca2+-activated force in a concentration 
dependent manner (Figure 3). As shown in Figures 3 and 4, the maximum augmentation 
by U46619 (10~5M) of Ca2+ activated force was less in the high altitude LCx (0.023 + 
0.006 gm/cm2) compared to the control LCx (0.044 + 0.010 gm/cm2,/> < 0.05). There 
was no difference in the response of the HA RCA (0.023 + 0.001) compared to the CON 
RCA (0.027 + 0.007 gm/cm2). In addition, there was no change in the U46619 pD2 (-log 
EC50) values between control and high altitude fetal coronary arteries (CON LCx 7.467




Studies conducted in our laboratory have shown that significant changes occur in the 
reactivity of fetal coronary arteries after exposure to long-term, high-altitude hypoxemia, 
namely decreased contractile responses to potassium and the thromboxane A2 mimetic, 
U46619. The purpose of this study was to explore the possible mechanisms underlying 
the observed decrease in contractility of fetal ovine coronary arteries exposed to chronic
hypoxia. Our two hypotheses were that in response to long-term, high-altitude 
intrauterine hypoxemia, a decrease occurs in the: 1) responsiveness of the contractile 
apparatus to Ca2+in fetal coronary arteries and 2) U46619-induced Ca2+ sensitization of
the myofilaments.
The major findings of this study are that, in {3-escin permeabilized fetal ovine
coronary arteries, 1) long-term, high-altitude hypoxemia significantly attenuates the 
maximum Ca2 ’ activated force in the left circumflex and left anterior descending 
coronary arteries but does not alter the Ca2 ' sensitivity (pD2) of the contractile apparatus
in fetal ovine coronary arteries and 2) long-term, high-altitude hypoxemia decreases the 
sensitizing effect of U46619 on Ca2+ activated force in the left circumflex coronary
artery. No changes in either of these responses were observed in the high-altitude right
coronary artery compared to the control.
In a previous study (Garcia et al., submitted), we demonstrated that chronic hypoxia
depressed Tmax responses to 90 mM KC1 in intact and nitric oxide synthase (NOS)
blocked LCx, LAD, and RCA. In our current study, in mechanically denuded coronary
artery preparations, we also observed a reduced contractile response to 90 mM KC1 in
60
the high altitude LCx and LAD compared to control (Fig. 1), but not in the RCA. One
possible mechanism that may explain the reduction in the contractile response to KC1 is
the effect of hypoxia on the calcium sensitivity of the contractile apparatus. In
chemically skinned rat portal vein preparations, exposure to acute hypoxia decreased 
Ca sensitivity of the myofilaments (Soloviev and Basilyuk, 1993 ).
We used (3-escin permeabilization to explore the possible alterations in the interaction 
of Ca" with the contractile mechanism in fetal coronary arteries exposed to long-term.
high-altitude hypoxemia. In (Lescin permeabilized preparations, cytosolic calcium
concentration is controlled while receptor-effector coupling is functionally intact
(Kobayashi et al., 1989). Permeabilization with the saponin ester, (3-escin, has been used
in a wide variety of smooth muscle including canine tracheal smooth muscle (Akao et
al., 1996), rabbit pulmonary artery (Kobayashi et al., 1989), rat coronary artery (Satoh et
al., 1994), rabbit femoral vein (Savineau and Marthan, 1994a), human bronchial smooth
muscle (Savineau and Marthan, 1994b), and rabbit mesenteric artery (Tomita et al..
1997). Furthermore, permeabilization with (3-escin has been successfully used in fetal
ovine cerebral vessels (Akopov et al., 1997) and neonatal rat portal veins (Bruce and
Nixon, 1997).
Exposure to long-term, high-altitude hypoxemia did not alter the myofilament Ca2+
sensitivity, as assessed by the pD2 (-log EC50) and Hill values (Table 1), in all the fetal 
ovine coronary artery groups studied. However, Ca" maximum responsiveness was
attenuated by chronic hypoxia in the fetal LCx and LAD, while the pCa-force
relationship was unaltered in the fetal RCA (Figure 2). Studies conducted by Soloviev
61
and Basilyuk (1993) in chemically skinned rat portal vein preparations demonstrated that 
exposure to acute hypoxia decreased Ca" sensitivity of the myofilaments and decreased 
maximal Ca -activated force produced. This is one possible mechanism responsible for 
the reduction in response to 90 mM KC1 observed in intact and NOS blocked (previous
study) and denuded (Fig. 1) LCx and LAD.
The interaction of Ca2+with the contractile apparatus of is an important regulator of
vascular smooth muscle contractions and that interaction can be modified by
physiological mechanisms (Karaki, 1989; Somlyo and Somlyo, 1994; Zhang, 1998).
Studies conducted in either a-toxin or (3-toxin permeabilized vascular smooth muscle
preparations have demonstrated that various agonists (e.g., U46619) can increase the
2+tension generated by the myofilaments independently of a rise in intracellular Ca
(Crichton et al., 1993).
2+The predominant mechanism involved in the regulation of contractile activity by Ca
in vascular smooth muscle is phosphorylation of the 20 kDa myosin light chain 
(Hathaway et al., 1991; Rembold, 1992). Activation of myosin light chain kinase 
(MLCK) by the Ca -calmodulin complex results in phosphorylation of myosin light
chain (MLC2o) which in turn, activates myosin ATPase. The phosphorylated myosin
cyclically binds to actin filaments producing vascular smooth muscle contraction.
MLCK can be phosphorylated by cyclic AMP (cAMP)-dependent protein kinase (Payne 
et al., 1986), which diminishes the affinity of MLCK for Ca2+-calmodulin (Hathaway et 
al., 1985). Soloviev and Basilyuk (1993) demonstrated that the decreased Ca 
sensitivity and maximal Ca2+-activated force in permeabilized portal vein preparations in
2+
62
response to hypoxia was associated with the following events: 1) inhibition of
phosphodiesterase activity, 2) stimulation of adenylate cyclase activity, 3) elevation of
cellular cAMP level, 4) cAMP-dependent phosphorylation of MLCK, and 5) subsequent
reduction of myosin light chain phosphorylation resulting in vasorelaxation. Other
mechanisms responsible for regulation of calcium sensitivity might include: 1) G protein
activation, 2) free calmodulin concentrations, and 3) regulation of myosin phosphatase
activity cannot be ruled out (Kitazawa et al., 1991; Hori and Karaki, 1998). Which of
these factors that might be responsible for the observed reduction in maximum response
to calcium in the high altitude LCx and LAD is not known.
U46619 augmented Ca -activated force in both control and high altitude (3-escin 
permeabilized fetal LCx and RCA. However, the enhancement of Ca2+-activated force
by U46619 was attenuated in the fetal ovine LCx exposed to high-altitude (Figure 4), but 
not in the RCA. In addition, there was no difference between the U46619-enhanced 
Ca~ sensitivity of myofilaments, as assessed by the pD2 values, between the CON and 
HA fetal coronary arteries.
Agonist-induced Caz sensitization results in increased MLC20 phosphorylation with 
a corresponding increase in tension, with no change in either the intracellular [Ca2+] or 
membrane potential (Karaki, 1989; Nishimura et al., 1989; Somlyo and Somlyo, 1994).
In Triton X-100 permeabilized porcine coronary arteries, contractions produced by 
U46619 were accompanied with little change in intracellular calcium (Bradley and 
Morgan, 1987). U46619 potentiates Ca -activated force in permeabilized preparations
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of rat mesenteric arteries (Himpens et al., 1990) and human umbilical arteries (Crichton
et al., 1993).
The thromboxane A2 receptor is functionally coupled to the G protein, Gq (Knezevic
et al., 1993; Kinsella et al., 1997). Upon binding to its receptor, U46619 produces
vascular smooth muscle contraction by: 1) activation of phospholipase C (PLC), 2) 
production of the second messenger 1,4,5-inositol phosphate, 3) release of Ca2+ from
intracellular stores, and 4) phosphorylation of myosin light chains (Dom and Becker,
1992). In vitro studies by Nishikawa et al. (1985) demonstrated that MLCK could also
be phosphorylated by protein kinase C (PKC) resulting in decreased MLC20
phosphorylation. However, it has been shown that PKC is not involved in the U46619-
stimulated MLC20 phosphorylation. Using the protein kinase C inhibitor, l-(5-
isoquinolinylsulfonyl)-2-methylpiperazine (H-7), Jiang et al. (1994) demonstrated
decreased U46619-activated force without alteration in the MLC20 phosphorylation in 
guinea pig aortic rings. Furthermore, experiments conducted in Ca2+-free media suggest 
that PKC is not involved in the Ca2+ sensitization effect of U46619 on contractile
elements in rat aortic preparations (Kurata et al, 1993).
Based on the observations by Soloviev and Basilyuk (1993) described earlier, it is 
possible that reduced U46619-induced Ca2+ sensitization in high altitude LCx is due to a 
decrease in MLC20 phosphorylation with a corresponding decrease in tension. This in
turn may partially explain the observed decrease in contractility of fetal ovine coronary
arteries to U46619 in response to long-term, high-altitude hypoxemia.
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Conclusion
In conclusion, our results suggest that the previously reported decrease in contractile 
responsiveness to potassium and U46619 in response to chronic hypoxia may be 
partially explained by an alteration in the Ca2+ responsiveness of the myofilaments
favoring a hypocontractile state in the fetal coronary arteries. These observations may
reflect adaptive mechanisms involved in the maintained redistribution of cardiac output 
to the fetal heart during long-term, high-altitude intrauterine hypoxemia. The
2_|_ . . . 9_|_
mechanisms underlying the regulation of Ca sensitivity and Ca responsiveness in
fetal coronary arteries remain to be explored.
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Table 1. Dose-response characteristics of Ca2+-mduced force in fetal ovine coronary 
arteries.
2+ Hill CoefficientpD2 for CaArtery
LCx
1.803 + 0.612 
1.325 + 0.125





1.197 + 0.128 
2.365 + 0.766









5.343 + 0.159 
5.381 + 0.115
Effects of long-term, high-altitude hypoxemia on Ca2 sensitivity (pD2) of (3-escin permeabilized 
fetal ovine coronary arteries. Data are means + S.E. (n=6-7). *Value significantly different from 
control (p < 0.05)
CHAPTER 4
THE EFFECTS OF CHRONIC HYPOXIA ON THE MORPHOLOGY OF FETAL
CORONARY ARTERIES: PRELIMINARY OBSERVATIONS
Felizabel C. Garcia1, Virginia M. Stiffel2, Charles A. Duscay3, and Raymond D. Gilbert4
i Student who conducted all the experiments, collected the data, and prepared the 
manuscript
^Research technician who helped conduct some experiments
3 jStudent’s research committee member who supervised the research and manuscript 
preparation





We have shown in our previous studies that significant changes occur in the reactivity
of fetal coronary arteries during exposure to long-term, high-altitude hypoxemia, namely 
decreased contractile responses to Ca~ , K , and the thromboxane A2 mimetic, U46619.
In a new set of studies currently underway in our laboratory, we are examining whether
these functional changes due to chronic hypoxia are associated with structural changes in
the coronary vessels. More specifically, we hypothesize that vascular remodeling in the
tunica media may contribute to the attenuated contractile capabilities of the fetal
coronary arteries exposed to long-term hypoxia.
Arteries are thick-walled vessels that contain, in addition to smooth muscle, a large
component of elastin and collagen fibers (Mohrman and Heller, 1991). Studies by
Bendeck and Langille (1991) have shown that rapid elastin and collagen (extracellular
matrix proteins) accumulation correlates with developmental changes in blood flow in
the aortas of sheep in the immediate perinatal period. The inelastic collagen interwoven
between elastic fibers limits the extent of stretching and prevents damage to the vascular
smooth muscle. The elastic fibers provide vessels with structural support and the
required resilience so they can recoil after stretch. The principal protein component of
elastic fibers is elastin. Studies by Langille (1993) have reported that vascular
remodeling or restructuring of the vessel wall components (e.g., elastin) occurs in
response to changes in blood flow.
To test our hypothesis, coronary arteries were collected from control (CON) and
high-altitude (HA) fetuses and histologically processed using Verhoeff s stain, an elastin
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specific stain (Pieraggi et al., 1986; Kouchi et al., 1997). We proposed that a structural
modification in the tunica media (e.g., decreased elastin deposition) due to chronic
hypoxia contributes to decreased contractility of fetal ovine coronary arteries. Structural
and functional changes in the coronary arteries may serve as adaptive mechanisms
responsible for the previously reported maintenance of cardiac output and enhanced
blood flow to the fetal heart during exposure to long-term, high-altitude hypoxia
(Kamitomo et al., 1993).
Materials and Methods
Isolated smooth muscle preparations
Fetal sheep were obtained from pregnant ewes that had been maintained near sea
level (~ 300 m, arterial PO2 = 102 + 2 mmHg) or at high altitude (Barcroft Laboratory,
White Mountain Research Station, Bishop, CA, altitude 3,820 m, arterial PO2 = 64 + 2
mmHg) for ~ 110 days beginning on day 30 gestation (term = 146 days). The latter
group of animals was transported (~ 7-h trip) to our laboratory at Loma Linda University
Medical Center (elevation 346 m). Immediately upon arrival a nonocclusive maternal
tracheal catheter was surgically placed to reestablish chronic hypoxia by administration
of nitrogen gas.
On the experimental day, the ewes were sedated intravenously with pentobarbital.
intubated, and maintained under general anesthesia with 1.5-2% halothane in oxygen
while we delivered the fetuses through a midline laparotomy. Fetuses ranged in age
from 138 to 141 days gestation (control 140.7 + 0.4 and high altitude 138.9 + 0.3). We
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immediately removed the fetal hearts via midline thoracotomy and placed them in
chilled Tyrode’s solution. Segments (> 1.6 mm od) of the right coronary artery (RCA),
left anterior descending (LAD), and left circumflex (LCx) coronary arteries were
dissected free from the hearts of control (CON) and high altitude (HA) fetuses and
cleared of connective tissue and fat. All side branches were excised.
Coronary artery rings were stored in formalin fixative at room temperature. Tissues
were deparaffinized in Hemo De, dehydrated with isopropyl alcohol, and embedded in
Epon. Cross-sections along the longitudinal axis were mounted on glass slides and
stained either with hematoxylin & eosin (H & E) or Verhoeff s stain (specific for
elastin).
Preliminary Observations
Morphological characteristics of fetal coronary arteries
Qualitatively, there were significant morphological differences between CON and
HA fetal coronary arteries. Figures 1, 2 and 3 depict the morphological changes in the
LCx, LAD, and RCA, respectively. In Verhoeff stained tissues samples obtained from
HA fetuses, decreased elastin deposition is demonstrated by the fragmented appearance
of elastin in the tunica medial layer.
Figures 4, 5, and 6 are H & E stained samples of the LCx, LAD, and RCA,
respectively. In the HA tissue samples, pyknotic nuclei are present in the tunica media
layer of the LCx and LAD. This nuclear change is not evident in the HA RCA.
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Discussion
The wall of an artery is comprised of the: 1) tunica intima (innermost layer), 2) tunica
media (middle layer), and 3) tunica adventitia (outermost layer). The tunica media
consists of mainly smooth muscle cells with varying amounts of elastic and collagenous
fibers. The principal protein component of elastic fibers is elastin. The elasticity of the
coronary arteries allows them to expand when the heart contracts and to return to normal
between cardiac contractions (Moore, 1992).
Vascular remodeling (vasoconstruction) is an active process of structural alteration
(e.g., rearrangement of the cellular and noncellular components of the vessel wall).
Arterial structural remodeling is usually an adaptive process that occurs in response to
long-term changes in hemodynamic conditions (Gibbons and Dzau, 1994). Little work
has been carried out on the effects of hypoxia on vascular remodeling in fetal coronary
vessels. There are, however, numerous morphological studies on the effects of hypoxia
on fetal pulmonary arteries.
Increased production of elastin and collagen (Stenmark et al., 1987) is an anatomic
change observed within the pulmonary arteries isolated from neonatal calves exposed to
simulated high altitude (Crouch et al., 1989) and chronic hypobaric hypoxia (Badesch et
al., 1989). This observed structural alteration in the extracellular matrix accumulation
may contribute towards the decreased fetal pulmonary blood flow associated with acute
hypoxemia (Faridy et al., 1988; Iwamoto et al., 1989). Based on the findings in the fetal
pulmonary circulation, one might speculate that the opposite occurs in the fetal coronary
r
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circulation, more specifically, a structural alteration in the extracellular matrix protein
elastin of the tunica media.
The structure of elastin present in the tunica media determines arterial function and
mechanical wall properties (Avolio et al., 1998). Qualitatively, our preliminary results
indicate that in response to chronic hypoxia, fetal coronary arteries exhibit altered elastin
deposition. The elastin present in HA LCx, LAD, and RCA appeared fragmented.
Vascular remodeling may enhance blood flow through the coronary arteries. Studies
conducted by Atkinson (1998) demonstrated that physical insults associated with
advancing age induced fragmentation of the medial elastic network in coronary arteries
coupled with arterial dilatation. Furthermore, to accommodate for increased blood flow.
arteries may either: 1) exhibit some enzymatic disruption of the cross-linked elastin
fibers without significant degradation or 2) allow some circumferential “slippage” of
elastin fibers (Langille, 1993). Whether any of these proposed mechanisms are
responsible for our preliminary findings in fetal coronary arteries exposed to long-term.
high-altitude hypoxia remains to be explored.
In support of our hypothesis, fetal coronary arteries exposed to chronic hypoxia
exhibited vascular remodeling in the tunica media. The structural alteration of elastin in
the tunica media of HA fetal coronary arteries may partially explain the previously 
reported attenuated contractile capabilities to K+, U46619, and Ca2+. The decreased
contractile capabilities of fetal coronary arteries in response to long-term hypoxia, in
turn, may be responsible for the maintenance of cardiac output and enhanced blood flow
to the fetal heart.
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The primary objective of this project was to investigate the effect of long-term, high-
altitude hypoxia on the contractility of fetal coronary arteries and to propose a
mechanism by which maintenance of blood flow redistribution to the fetal heart occurs
in response to chronic hypoxia.
Initially, we hypothesized that in response exposure to long-term, high-altitude
hypoxia, there is a decrease in the contractile capabilities of the fetal coronary arteries
(Chapter 2). To test this hypothesis, we examined the contractile responses to the 
potassium (K+) and the thromboxane A2 mimetic, U46619. Chronic hypoxia caused a
significantly depressed maximum contractile response (Tmax) to 90 mM KC1 in the left
circumflex (LCx), left anterior descending (LAD), and right coronary arteries (RCA).
The contractile response to 90 mM KC1 was not altered by the nitric oxide synthase
(NOS) inhibitors, L-NNA and L-NAME. Exposure to long-term hypoxia produced no
significant alteration in the maximum U46619 response in either intact of NOS blocked
LCx and LAD. In the RCA, the Tmax response to U46619 was unchanged by NOS
blockade in the control (CON) group. However, in the high altitude (HA) group, NOS
blockade resulted in a significant increase in Tmax. This resulted in the Tmax response to
U46619 in the high altitude l-NNA/l-NAME treated RCA to be significantly higher
than its control counterpart. In addition, chronic hypoxia produced a significant
decrease in sensitivity to U46619, as measured by the excitatory pDi, in all of the
coronary artery groups studied. Maximum relaxation response and sensitivity (as
measured by inhibitory pD2) to the vasodilator, adenosine (ADO) was unaltered by long­
term hypoxia and NOS blockade in all vessel groups examined.
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Based on these initial studies, exposure to long-term, high-altitude hypoxia
significantly altered the contractile capabilities of isolated fetal coronary arteries.
Chronic hypoxia significantly diminished the maximum contractile response to 90 mM
KC1 and sensitivity to U46619. Nitric oxide did not play a significant role in the
pharmacological responses of control and high altitude LCx and LAD to the contractile 
agonists, K+ and U46619. Basal nitric oxide production appeared to only influence the
pharmacological responsiveness to U46619 in the RCA. The decreased contractile
capabilities of fetal coronary arteries may serve as an adaptive mechanism involved in
the maintenance of blood flow redistribution to the fetal heart during exposure to long­
term, high-altitude hypoxia.
To further examine the diminished contractility of fetal coronary arteries in response
to chronic hypoxia, we investigated the role of calcium using (3-escin permeabilized 
preparations in which intracellular calcium ([Ca ],) was held constant by use of calcium 
chelators and depletion of |Ca^+j, stores with the calcium ionophore, A23187. The 
major findings of Chapter 3 were: 1) long-term, high-altitude hypoxia decreased the 
responsiveness of the contractile apparatus to Ca2+ in the LCx and LAD but Ca 
sensitivity was unaltered in all vessel groups studied and 2) long-term, high-altitude 
hypoxia attenuated the sensitizing effect of U46619 on Ca:+ activated force in the left 
circumflex coronary artery. The alteration in Ca2+ responsiveness of the myofilaments 
in response to long-term hypoxia may partially explain the decreased contractile 





(e.g., regulation of myosin phosphatase activity) in fetal coronary vessels remain to be
explored.
Anecdotal findings from a new group of studies were described in Chapter 4.
Qualitatively, our preliminary results indicate that in response to long-term, high-altitude
hypoxia, fetal coronary arteries undergo vascular remodeling. Using an elastin specific
stain, Verhoeff s stain, LCx, LAD, and RCA samples obtained from HA fetuses
exhibited structural alteration of elastin (fragmented appearance) in the tunica medial
layer. In histologically processed H & E stained tissue samples, pyknotic nuclei were
present in the tunica media layer of the LCx and LAD obtained from high altitude
fetuses.
Our data suggest that changes in the structure and function of fetal coronary arteries
are crucial for the adaptation to long-term, high-altitude hypoxia. In response to chronic 
hypoxia, fetal coronary arteries exhibited decreased contractile capabilities to Ca2+, K+,
and the thromboxane A2 mimetic, U46619. In addition to this functional change.
exposure to long-term hypoxia resulted in structural modifications in the tunica media
layer of fetal coronary vessels. These adaptive mechanisms in the coronary arteries
favor a hypocontractile state, which may partially explain the maintenance of blood flow
redistribution to the fetal heart in response to long-term, high-altitude hypoxia.
